Fig. 4
From: Ecto-GPR37: a potential biomarker for Parkinson’s disease
Detection of ecto-GPR37 and α-synuclein in CSF of NC and PD participants from Karolinska Hospital. a The CSF ecto-GPR37 level was significantly higher in PD patients than in NCs, irrespective of sex. b ROC curve analysis of CSF ecto-GPR37. c CSF α-synuclein did not differ between the NC and PD participants. d ROC curve analysis of CSF α-synuclein. *P < 0.05, ****P < 0.0001 (Mann-Whitney U-tests)